Valuation: DVx Inc.

Market Cap 11.86B 72.98M 63.79M 58.99M 54.13M 102M 7.03B 104M 704M 276M 3.43B 274M 268M P/E 2024
61.4x
P/E 2025 23.9x
Enterprise Value 6.81B 41.92M 36.64M 33.88M 31.09M 58.85M 4.04B 59.87M 404M 159M 1.97B 157M 154M EV / Sales 2024
0.05x
EV / Sales 2025 0.08x
Free-Float
27.8%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Director of Finance/CFO 52 2024-05-31
President 49 2026-06-25
Corporate Officer/Principal 52 -
Director TitleAgeSince
Chairman 61 2026-06-25
Director/Board Member 65 2020-05-31
Director/Board Member - 2022-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%-3.75% - - 61.54M
+1.42%+5.23%+27.31%+10.00% 9.93B
-1.93%+18.24% - - 1.51B
-0.09%+1.13%+12.66%+2.43% 1.32B
+1.32%+3.34%+3.45%-10.46% 1.07B
+3.90%+11.38%+64.75%+37.29% 648M
+0.45%+8.28%-17.32%-55.30% 619M
-0.57%+5.08%+107.20%+160.65% 419M
-0.41%+3.90%-9.68%-12.81% 423M
+3.31%+12.88%-53.03%-80.68% 278M
Average +0.85%+5.68%+16.92%+6.39% 1.63B
Weighted average by Cap. +0.96%+5.59%+23.73%+8.21%

Financials

2024 2025
Net sales 45.85B 282M 247M 228M 209M 396M 27.2B 403M 2.72B 1.07B 13.28B 1.06B 1.04B 50.32B 310M 271M 250M 230M 435M 29.85B 442M 2.99B 1.17B 14.58B 1.16B 1.14B
Net income 172M 1.06M 925K 856K 785K 1.49M 102M 1.51M 10.21M 4.01M 49.82M 3.98M 3.89M 410M 2.52M 2.21M 2.04M 1.87M 3.54M 243M 3.6M 24.33M 9.56M 119M 9.48M 9.27M
Net Debt -7.48B -46.03M -40.23M -37.21M -34.14M -64.62M -4.43B -65.74M -444M -174M -2.17B -173M -169M -5.05B -31.06M -27.15M -25.11M -23.04M -43.61M -2.99B -44.36M -299M -118M -1.46B -117M -114M
Logo DVx Inc.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
Employees
334
Date Price Change Volume
26-07-16 JP¥961.00 +1.16% 4,100
26-07-15 JP¥950.00 0.00% 2,900
26-07-14 JP¥950.00 0.00% 2,200
26-07-13 JP¥950.00 -1.35% 5,400
26-07-10 JP¥963.00 -0.21% 2,200

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3079 Stock